David A. Lipson

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Akram Khan, Cody Benthin, Brian Zeno et al. · Critical Care · 2017 · 631 citations · Full text

Medicine, Pharmacokinetics, Pharmacotherapy +15

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Steven Pascoe, Neil Barnes, Guy Brusselle et al. · The Lancet Respiratory Medicine · 2019 · 240 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15